Get Started in Minutes
How Vyvgart Copay Assistance Works
1 – Check Your Coverage/Benefits Verification
Our team of expert billers finds the best avenues of coverage that minimize out-of-pocket costs.
2 – Transfer Prescription to AmeriPharma
We process your prescription by working with your previous pharmacy or prescriber, making the transition quick and easy.
3 – Prior Authorization
Our team of specialists obtains approval from your insurance companies within 24 to 72 hours.
6 – Delivery Coordination
Medications are always delivered in strict compliance with the specific requirements for immune globulin shipping. Next-day and overnight cold-chain deliveries are coordinated around your schedule.
What Is Vyvgart?
Vyvgart (generic name: efgartigimod alfa-fcab) is a new class of medication. It consists of a human antibody (IgG1) fragment.
Vyvgart works through attaching to a type of receptor in our body that is known as “neonatal Fc receptor” (FcRn) and as a result of this attachment, the FcRn is unable to recycle back IgG into circulation, thus lowering the total IgG levels as well as the other antibodies (AChR) that are found in high levels in cases of myasthenia gravis.
What Is Vyvgart Used For?
Vyvgart is used as a chronic immunosuppressive therapy for the treatment of generalized myasthenia gravis in adults who are anti-acetylcholine receptor antibody positive (AChR+).
Myasthenia gravis is a chronic autoimmune disorder in which the body’s own antibodies start attacking and destroying the connection that is responsible for communication between nerves and muscles. This results in weakness of the skeletal muscles.
Myasthenia gravis generally affects voluntary muscles of the body, mainly those controlling the limbs, mouth, throat, and eyes.
Copay and Financial Assistance
AmeriPharma Specialty Care alleviates financial burdens for patients and their families
Advanced software locates funding sources to match you with top-dollar foundation programs
One of our copay assistance specialists will assist with the application process
Automatic updates will be sent to you and your physician on the status of the funding
Vyvgart Side Effects
- Decreased neutrophils (a type of white blood cell that acts as the immune system’s first line of defense)
- Decreased white blood cell count
- Antibody development
- Respiratory tract infection
- Urinary tract infection
- Tingling or prickling sensations
- Increased or decreased sensitivity of any of the senses (sight, sound, touch, or smell)
- Muscle pain
- Hypersensitivity reaction
- Angioedema (swelling underneath the skin)
Directions for Use
Vyvgart is administered as follows:
Dose is calculated as 10 mg/kg (with a maximum dose being 1200 mg) and is administered once weekly for 4 weeks. Subsequent treatment cycles may be administered based on clinical evaluation and no sooner than 50 days from the start of the previous treatment cycle.
Vyvgart is first diluted and then administered intravenously using a catheter that is inserted into the vein. Infusion is done over 1 hour. Infusions are followed by a 1-hour monitoring time for any signs or symptoms of an infusion reaction.
You should be up-to-date with all immunizations before initiating therapy. Avoid the use of live vaccines when undergoing Vyvgart treatment.